Literature DB >> 21595648

Global arginine bioavailability in Tanzanian sickle cell anaemia patients at steady-state: a nested case control study of deaths versus survivors.

Sharon E Cox, Julie Makani, Albert N Komba, Deogratius Soka, Charles R Newton, Fenella J Kirkham, Andrew M Prentice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21595648      PMCID： PMC3592384          DOI： 10.1111/j.1365-2141.2011.08715.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.

Authors:  Mark T Gladwin; Gregory J Kato
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

2.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

3.  Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production.

Authors:  Bert K Lopansri; Nicholas M Anstey; J Brice Weinberg; Gregory J Stoddard; Maurine R Hobbs; Marc C Levesque; Esther D Mwaikambo; Donald L Granger
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

4.  Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization.

Authors:  Julie Makani; Albert N Komba; Sharon E Cox; Julie Oruo; Khadija Mwamtemi; Jesse Kitundu; Pius Magesa; Stella Rwezaula; Elineema Meda; Josephine Mgaya; Kisali Pallangyo; Emelda Okiro; David Muturi; Charles R Newton; Gregory Fegan; Kevin Marsh; Thomas N Williams
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

5.  Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk.

Authors:  W H Wilson Tang; Zeneng Wang; Leslie Cho; Danielle M Brennan; Stanley L Hazen
Journal:  J Am Coll Cardiol       Date:  2009-06-02       Impact factor: 24.094

6.  Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease.

Authors:  Maria L Jison; Peter J Munson; Jennifer J Barb; Anthony F Suffredini; Shefali Talwar; Carolea Logun; Nalini Raghavachari; John H Beigel; James H Shelhamer; Robert L Danner; Mark T Gladwin
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113
  6 in total
  6 in total

1.  Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.

Authors:  Claudia R Morris; Hae-Young Kim; Elizabeth S Klings; John Wood; John B Porter; Felicia Trachtenberg; Nancy Sweeters; Nancy F Olivieri; Janet L Kwiatkowski; Lisa Virzi; Kathryn Hassell; Ali Taher; Ellis J Neufeld; Alexis A Thompson; Sandra Larkin; Jung H Suh; Elliott P Vichinsky; Frans A Kuypers
Journal:  Br J Haematol       Date:  2015-04-24       Impact factor: 6.998

Review 2.  Arginases and arginine deficiency syndromes.

Authors:  Sidney M Morris
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-01       Impact factor: 4.294

3.  Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.

Authors:  Claudia R Morris; Lou Ann S Brown; Michael Reynolds; Carlton D Dampier; Peter A Lane; Amanda Watt; Polly Kumari; Frank Harris; Shaminy Manoranjithan; Reshika D Mendis; Janet Figueroa; Sruti Shiva
Journal:  Blood       Date:  2020-09-17       Impact factor: 22.113

4.  Nutritional perspectives on sickle cell disease in Africa: a systematic review.

Authors:  Eunice Berko Nartey; Jonathan Spector; Seth Adu-Afarwuah; Catherine L Jones; Alan Jackson; Agartha Ohemeng; Rajiv Shah; Alice Koryo-Dabrah; Amma Benneh-Akwasi Kuma; Hyacinth I Hyacinth; Matilda Steiner-Asiedu
Journal:  BMC Nutr       Date:  2021-03-18

Review 5.  The role of the arginine metabolome in pain: implications for sickle cell disease.

Authors:  Nitya Bakshi; Claudia R Morris
Journal:  J Pain Res       Date:  2016-03-30       Impact factor: 3.133

6.  Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial.

Authors:  Sharon E Cox; Elizabeth A Ellins; Alphonce I Marealle; Charles R Newton; Deogratias Soka; Philip Sasi; Gian Luca Di Tanna; William Johnson; Julie Makani; Andrew M Prentice; Julian P Halcox; Fenella J Kirkham
Journal:  Lancet Haematol       Date:  2018-03-13       Impact factor: 30.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.